Intelligence Platform

Patents

Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8710223

Protein kinase C inhibitors and uses thereof

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8710081

5-lipoxygenase-activating protein (FLAP) inhibitors

Panmira Pharmaceuticals, LLC · Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8710032

Inhibitors of the mevalonate pathway of Streptococcus pneumoniae

Northwestern University · Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8703938

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8697698

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8697709

Fused ring heteroaryl kinase inhibitors

The Regents of the University of California · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8697704

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8697699

Imidazopyrazine SYK inhibitors

GILEAD CONNECTICUT, INC. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8697628

Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes

The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8691501

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosc

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8691868

Neprilysin inhibitors

Theravance, Inc. · Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8691852

Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors

Amirall, S.A. · Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8691848

Inhibitors of caspases

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8691831

Heterocyclic aspartyl protease inhibitors

Pharmacopeia Drug Discovery, Inc. · Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8691828

Thienopyrimidine as CDC7 kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8691184

Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8691758

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8685926

Compositions and method for CaMKII inhibitors and uses thereof

The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8686184

Neprilysin inhibitors

Theravance, Inc. · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8686143

Compounds useful as inhibitors of Janus kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8686010

Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8680046

Inhibitors of viral integrase and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8669249

Poly (ADP-ribose) polymerase (PARP) inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8669081

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted